These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32633461)

  • 41. Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor.
    Bosbach B; Rossi F; Yozgat Y; Loo J; Zhang JQ; Berrozpe G; Warpinski K; Ehlers I; Veach D; Kwok A; Manova K; Antonescu CR; DeMatteo RP; Besmer P
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8448-E8457. PubMed ID: 28923937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRD4 promotes tumor progression and NF-κB/CCL2-dependent tumor-associated macrophage recruitment in GIST.
    Mu J; Sun P; Ma Z; Sun P
    Cell Death Dis; 2019 Dec; 10(12):935. PubMed ID: 31819043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Histology and molecular biology of GIST].
    Emile JF
    Bull Acad Natl Med; 2012; 196(4-5):835-44. PubMed ID: 23550446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors.
    Liu W; Zeng X; Yin Y; Li C; Yang W; Wan W; Shi L; Wang G; Tao K; Zhang P
    Gastric Cancer; 2020 Jan; 23(1):39-51. PubMed ID: 31197522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteogenomics for the Study of Gastrointestinal Stromal Tumors.
    Kondo T
    Adv Exp Med Biol; 2016; 926():139-151. PubMed ID: 27686810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M; Majidi M; Lasota J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.
    Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y
    PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer biology of small gastrointestinal stromal tumors (<2 cm): What is the risk of malignancy?
    Søreide K
    Eur J Surg Oncol; 2017 Jul; 43(7):1344-1349. PubMed ID: 28222971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycolysis in gastrointestinal stromal tumor: a brief overview.
    Shima T; Taniguchi K; Inomata Y; Arima J; Lee SW
    Neoplasia; 2024 Sep; 55():101022. PubMed ID: 38943997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hedgehog signalling pathway activation in gastrointestinal stromal tumours is mediated by primary cilia.
    Iruzubieta P; Monzón M; Castiella T; Ramírez T; Junquera C
    Gastric Cancer; 2020 Jan; 23(1):64-72. PubMed ID: 31267361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors.
    Hsueh YS; Chang HH; Shan YS; Sun HS; Fletcher JA; Li CF; Chen LT
    Oncogene; 2019 Sep; 38(38):6550-6565. PubMed ID: 31363162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M; Lasota J
    Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor.
    Yamamoto H; Kohashi K; Fujita A; Oda Y
    Mod Pathol; 2013 Apr; 26(4):563-71. PubMed ID: 23196799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistopathological and molecular genetic features of a case in which gastrointestinal stromal tumor recurred five times.
    Inoue T; Suzuki T; Nakagawa K; Kurokawa Y; Satomi S; Moriya T; Sasano N; Sasano H
    Pathol Int; 2004 Mar; 54(3):196-200. PubMed ID: 14989743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coding and Non-coding: Molecular Portrait of GIST and its Clinical Implication.
    Bure I; Haller F; Zaletaev DV
    Curr Mol Med; 2018; 18(4):252-259. PubMed ID: 30289069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Gastrointestinal stromal tumors].
    Kit OI; Todorov SS
    Arkh Patol; 2012; 74(4):63-5. PubMed ID: 22997960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical Pathology of Gastrointestinal Stromal Tumors: Practical Implications of Morphologic and Molecular Heterogeneity for Precision Medicine.
    Charville GW; Longacre TA
    Adv Anat Pathol; 2017 Nov; 24(6):336-353. PubMed ID: 28820749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
    Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
    Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.